- Home
- PODC vs ZYXI Comparison
PODC vs ZYXI Comparison
Compare PODC & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- ZYXI
- Stock Information
- Founded
- PODC 2013
- ZYXI 1996
- Country
- PODC United States
- ZYXI United States
- Employees
- PODC N/A
- ZYXI N/A
- Industry
- PODC
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PODC
- ZYXI Health Care
- Exchange
- PODC Nasdaq
- ZYXI Nasdaq
- Market Cap
- PODC 47.8M
- ZYXI 44.8M
- IPO Year
- PODC N/A
- ZYXI N/A
- Fundamental
- Price
- PODC $1.65
- ZYXI $1.49
- Analyst Decision
- PODC
- ZYXI Hold
- Analyst Count
- PODC 0
- ZYXI 3
- Target Price
- PODC N/A
- ZYXI $3.00
- AVG Volume (30 Days)
- PODC 38.3K
- ZYXI 82.4K
- Earning Date
- PODC 11-06-2025
- ZYXI 10-23-2025
- Dividend Yield
- PODC N/A
- ZYXI N/A
- EPS Growth
- PODC N/A
- ZYXI N/A
- EPS
- PODC N/A
- ZYXI N/A
- Revenue
- PODC $53,954,000.00
- ZYXI $144,808,000.00
- Revenue This Year
- PODC $17.91
- ZYXI N/A
- Revenue Next Year
- PODC $14.41
- ZYXI $7.07
- P/E Ratio
- PODC N/A
- ZYXI N/A
- Revenue Growth
- PODC 17.74
- ZYXI N/A
- 52 Week Low
- PODC $1.10
- ZYXI $1.23
- 52 Week High
- PODC $2.94
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- PODC 46.64
- ZYXI 42.64
- Support Level
- PODC $1.51
- ZYXI $1.42
- Resistance Level
- PODC $1.80
- ZYXI $1.61
- Average True Range (ATR)
- PODC 0.11
- ZYXI 0.06
- MACD
- PODC -0.01
- ZYXI 0.01
- Stochastic Oscillator
- PODC 32.79
- ZYXI 25.38
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.